Seven Eight Capital LP Makes New $401,000 Investment in Agilent Technologies, Inc. (NYSE:A)

Seven Eight Capital LP bought a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 3,092 shares of the medical research company’s stock, valued at approximately $401,000.

Other institutional investors have also recently made changes to their positions in the company. Crewe Advisors LLC lifted its position in Agilent Technologies by 114.8% during the 2nd quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock valued at $25,000 after acquiring an additional 101 shares during the period. Livelsberger Financial Advisory purchased a new position in shares of Agilent Technologies during the fourth quarter valued at approximately $26,000. Ridgewood Investments LLC bought a new stake in shares of Agilent Technologies in the 2nd quarter worth approximately $29,000. Rise Advisors LLC grew its stake in shares of Agilent Technologies by 527.8% in the 1st quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock worth $33,000 after buying an additional 190 shares during the last quarter. Finally, YHB Investment Advisors Inc. bought a new position in Agilent Technologies during the 1st quarter valued at approximately $34,000. Institutional investors own 87.42% of the company’s stock.

Insiders Place Their Bets

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,958 shares of the firm’s stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total transaction of $283,910.00. Following the sale, the chief executive officer now owns 24,118 shares in the company, valued at approximately $3,497,110. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have commented on the company. TD Cowen boosted their target price on Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. Stifel Nicolaus reiterated a “buy” rating and issued a $151.00 price target on shares of Agilent Technologies in a research note on Monday, August 26th. Evercore ISI raised their price objective on shares of Agilent Technologies from $130.00 to $135.00 and gave the company an “in-line” rating in a research note on Thursday, August 22nd. Wells Fargo & Company assumed coverage on shares of Agilent Technologies in a research note on Tuesday, August 27th. They issued an “overweight” rating and a $157.00 target price on the stock. Finally, UBS Group raised their price target on shares of Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a research report on Thursday, August 22nd. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $141.60.

Agilent Technologies Trading Down 1.3 %

Shares of NYSE:A opened at $140.09 on Monday. The stock’s 50-day simple moving average is $137.87 and its two-hundred day simple moving average is $139.16. The stock has a market capitalization of $40.87 billion, a price-to-earnings ratio of 33.12, a PEG ratio of 6.43 and a beta of 1.05. Agilent Technologies, Inc. has a 52-week low of $96.80 and a 52-week high of $155.35. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.37 and a current ratio of 1.78.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, beating analysts’ consensus estimates of $1.26 by $0.06. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The business had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.56 billion. During the same period in the prior year, the company earned $1.43 earnings per share. The firm’s revenue was down 5.6% on a year-over-year basis. Analysts expect that Agilent Technologies, Inc. will post 5.24 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 23rd. Shareholders of record on Tuesday, October 1st will be issued a dividend of $0.236 per share. This represents a $0.94 annualized dividend and a yield of 0.67%. The ex-dividend date is Tuesday, October 1st. Agilent Technologies’s dividend payout ratio is presently 22.22%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.